Chief Financial Officer
Tue, Apr 21, 2026
Apr 21
exercised or converted securities in PCRX
2,845 shares @ $0.00
Decreased holdings by -1.70%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
PCRXPacira BioSciences, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+4.02%
1M-7.55%
3M—
6M—
1Y—